NCT06229522View on ClinicalTrials.gov

Patients Derived Organoids as a Promising Tool to Tailor Ovarian Cancer Therapies (PANDORA).

RecruitingOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

November 16, 2023

Primary Completion Date

December 31, 2037

Study Completion Date

December 31, 2037

Conditions

Ovarian Cancer

Trial Locations (1)

33081

RECRUITING

Centro di Riferimento Oncologico (CRO) di Aviano - IRCCS, Aviano

All Listed Sponsors

lead

Centro di Riferimento Oncologico - Aviano

OTHER